{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:15:49Z","timestamp":1770963349801,"version":"3.50.1"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,2,19]],"date-time":"2008-02-19T00:00:00Z","timestamp":1203379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1038\/ncpneph0762","type":"journal-article","created":{"date-parts":[[2008,2,19]],"date-time":"2008-02-19T13:18:46Z","timestamp":1203427126000},"page":"194-206","source":"Crossref","is-referenced-by-count":18,"title":["Preventive health care in chronic kidney disease and end-stage renal disease"],"prefix":"10.1038","volume":"4","author":[{"given":"Devasmita","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Luna-Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,19]]},"reference":[{"key":"BFncpneph0762_CR1","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1681\/ASN.2004110910","volume":"16","author":"AT Kausz","year":"2005","unstructured":"Kausz AT et al. (2005) General medical care among patients with chronic kidney disease: opportunities for improving outcomes. J Am Soc Nephrol 16: 3092\u20133101","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 87","key":"BFncpneph0762_CR2","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1046\/j.1523-1755.64.s87.5.x","volume":"64","author":"AJ Collins","year":"2003","unstructured":"Collins AJ et al. (2003) Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int 64 (Suppl 87): S24\u2013S31","journal-title":"Kidney Int"},{"key":"BFncpneph0762_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1046\/j.1525-1497.2002.11021.x","volume":"17","author":"WC Winkelmayer","year":"2002","unstructured":"Winkelmayer WC et al. (2002) Preventive health care measures before and after start of renal replacement therapy. J Gen Intern Med 17: 588\u2013595","journal-title":"J Gen Intern Med"},{"key":"BFncpneph0762_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1053\/j.ackd.2006.04.004","volume":"13","author":"SB Naqvi","year":"2006","unstructured":"Naqvi SB and Collins AJ (2006) Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis 13: 199\u2013204","journal-title":"Adv Chronic Kidney Dis"},{"key":"BFncpneph0762_CR5","first-page":"192","volume":"16","author":"M Haag-Weber","year":"1996","unstructured":"Haag-Weber M and H\u00f6rl WH (1996) Dysfunction of polymorphonuclear leukocytes in uremia. Semin Nephrol 16: 192\u2013201","journal-title":"Semin Nephrol"},{"key":"BFncpneph0762_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-196801000-00001","volume":"47","author":"JZ Montgomerie","year":"1968","unstructured":"Montgomerie JZ et al. (1968) Renal failure and infection. Medicine (Baltimore) 47: 1\u201332","journal-title":"Medicine (Baltimore)"},{"key":"BFncpneph0762_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1525-139X.2004.17104.x","volume":"17","author":"A Kausz","year":"2004","unstructured":"Kausz A and Pahari D (2004) The value of vaccination in chronic kidney disease. Semin Dial 17: 9\u201311","journal-title":"Semin Dial"},{"key":"BFncpneph0762_CR8","first-page":"253","volume":"14","author":"B Descamps-Latscha","year":"1994","unstructured":"Descamps-Latscha B et al. (1994) Immune system dysregulation in uremia. Semin Nephrol 14: 253\u2013260","journal-title":"Semin Nephrol"},{"key":"BFncpneph0762_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/ncpneph0447","volume":"3","author":"R Katneni","year":"2007","unstructured":"Katneni R and Hedayati SS (2007) Central venous catheter-related bacteremia in chronic hemodialysis patients: epidemiology and evidence-based management. Nat Clin Pract Nephrol 3: 256\u2013266","journal-title":"Nat Clin Pract Nephrol"},{"key":"BFncpneph0762_CR10","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/j.1523-1755.2000.00337.x","volume":"58","author":"MJ Sarnak","year":"2000","unstructured":"Sarnak MJ and Jaber BL (2000) Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 58: 1758\u20131764","journal-title":"Kidney Int"},{"key":"BFncpneph0762_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1023\/A:1024466206414","volume":"34","author":"JL Bibb","year":"2002","unstructured":"Bibb JL et al. (2002) Pyocystis in patients on chronic dialysis: a potentially misdiagnosed syndrome. Int Urol Nephrol 34: 415\u2013418","journal-title":"Int Urol Nephrol"},{"key":"BFncpneph0762_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0736-4679(00)00198-0","volume":"19","author":"EE Remer","year":"2000","unstructured":"Remer EE and Peacock W (2000) Pyocystis: two case reports of patients in renal failure. J Emerg Med 19: 131\u2013133","journal-title":"J Emerg Med"},{"key":"BFncpneph0762_CR13","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S0022-5347(17)47404-0","volume":"134","author":"JA Lees","year":"1985","unstructured":"Lees JA et al. (1985) Pyocystis, pyonephrosis and perinephric abscess in end stage renal disease. J Urol 134: 716\u2013719","journal-title":"J Urol"},{"key":"BFncpneph0762_CR14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1378\/chest.07-0005","volume":"132","author":"CH Chen","year":"2007","unstructured":"Chen CH et al. (2007) Different bacteriology and prognosis of thoracic empyemas between patients with chronic and end-stage renal disease. Chest 132: 532\u2013539","journal-title":"Chest"},{"key":"BFncpneph0762_CR15","first-page":"183","volume":"16","author":"B Descamps-Latscha","year":"1996","unstructured":"Descamps-Latscha B and Chatenoud L (1996) T cells and B cells in chronic renal failure. Semin Nephrol 16: 183\u2013191","journal-title":"Semin Nephrol"},{"key":"BFncpneph0762_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000170143","volume":"12","author":"CJ Kelly","year":"1994","unstructured":"Kelly CJ (1994) T cell function in chronic renal failure and dialysis. Blood Purif 12: 36\u201341","journal-title":"Blood Purif"},{"key":"BFncpneph0762_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/oxfordjournals.ndt.a091858","volume":"4","author":"M Beaman","year":"1989","unstructured":"Beaman M et al. (1989) T-cell-independent and T-cell-dependent antibody responses in patients with chronic renal failure. Nephrol Dial Transplant 4: 216\u2013221","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0762_CR18","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.2215\/CJN.01230406","volume":"1","author":"N Aslam","year":"2006","unstructured":"Aslam N et al. (2006) Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients. Clin J Am Soc Nephrol 1: 1226\u20131233","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl","key":"BFncpneph0762_CR19","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/00002480-200011000-00031","volume":"46","author":"B Piraino","year":"2000","unstructured":"Piraino B (2000) Staphylococcus aureus infections in dialysis patients: focus on prevention. ASAIO J 46 (Suppl): S13\u2013S17","journal-title":"ASAIO J"},{"key":"BFncpneph0762_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1681\/ASN.2004090773","volume":"16","author":"J Bernardini","year":"2005","unstructured":"Bernardini J et al. (2005) Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 16: 539\u2013545","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0762_CR21","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/ndt\/17.10.1802","volume":"17","author":"DW Johnson","year":"2002","unstructured":"Johnson DW et al. (2002) A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 17: 1802\u20131807","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0762_CR22","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/089686080102100604","volume":"21","author":"R Annigeri","year":"2001","unstructured":"Annigeri R et al. (2001) Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 21: 554\u2013559","journal-title":"Perit Dial Int"},{"key":"BFncpneph0762_CR23","first-page":"67","volume":"20","author":"C Cavdar","year":"2004","unstructured":"Cavdar C et al. (2004) Emergence of resistance in staphylococci after long-term mupirocin application in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial 20: 67\u201370","journal-title":"Adv Perit Dial"},{"key":"BFncpneph0762_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1053\/j.ajkd.2006.12.014","volume":"49","author":"M Sedlacek","year":"2007","unstructured":"Sedlacek M et al. (2007) Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. Am J Kidney. Dis 49: 401\u2013408","journal-title":"Am J Kidney. Dis"},{"key":"BFncpneph0762_CR25","first-page":"34","volume":"68","author":"JT Klassen","year":"2002","unstructured":"Klassen JT and Krasko BM (2002) The dental health status of dialysis patients. J Can Dent Assoc 68: 34\u201338","journal-title":"J Can Dent Assoc"},{"key":"BFncpneph0762_CR26","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1053\/j.ajkd.2004.12.009","volume":"45","author":"AV Kshirsagar","year":"2005","unstructured":"Kshirsagar AV et al. (2005) Periodontal disease is associated with renal insufficiency in the Atherosclerosis Risk In Communities (ARIC) study. Am J Kidney Dis 45: 650\u2013657","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0762_CR27","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.106.183095","volume":"116","author":"W Wilson","year":"2007","unstructured":"Wilson W et al. (2007) Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116: 1736\u20131754","journal-title":"Circulation"},{"key":"BFncpneph0762_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00000441-200304000-00010","volume":"325","author":"E Umana","year":"2003","unstructured":"Umana E et al. (2003) Valvular and perivalvular abnormalities in end-stage renal disease. Am J Med Sci 325: 237\u2013242","journal-title":"Am J Med Sci"},{"key":"BFncpneph0762_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1440-1797.2004.00245.x","volume":"9","author":"DC Tong","year":"2004","unstructured":"Tong DC and Walker RJ (2004) Antibiotic prophylaxis in dialysis patients undergoing invasive dental treatment. Nephrology (Carlton) 9: 167\u2013170","journal-title":"Nephrology (Carlton)"},{"key":"BFncpneph0762_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1754-4505.1999.tb01409.x","volume":"19","author":"CW Werner","year":"1999","unstructured":"Werner CW and Saad TF (1999) Prophylactic antibiotic therapy prior to dental treatment for patients with end-stage renal disease. Spec Care Dentist 19: 106\u2013111","journal-title":"Spec Care Dentist"},{"key":"BFncpneph0762_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/BF02553255","volume":"25","author":"S Kumar","year":"1982","unstructured":"Kumar S et al. (1982) Bacteremia associated with lower gastrointestinal endoscopy, fact or fiction? I. Colonoscopy. Dis Colon Rectum 25: 131\u2013134","journal-title":"Dis Colon Rectum"},{"key":"BFncpneph0762_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/BF02554673","volume":"26","author":"S Kumar","year":"1983","unstructured":"Kumar S et al. (1983) Bacteremia associated with lower gastrointestinal endoscopy: fact or fiction? II. Proctosigmoidoscopy. Dis Colon Rectum 26: 22\u201324","journal-title":"Dis Colon Rectum"},{"key":"BFncpneph0762_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1046\/j.1525-139X.2003.03010.x","volume":"16","author":"MM Hussein","year":"2003","unstructured":"Hussein MM et al. (2003) Tuberculosis and chronic renal disease. Semin Dial 16: 38\u201344","journal-title":"Semin Dial"},{"key":"BFncpneph0762_CR34","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1093\/ndt\/gfi141","volume":"20","author":"MS Shankar","year":"2005","unstructured":"Shankar MS et al. (2005) The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant 20: 2720\u20132724","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0762_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.5414\/CNP67217","volume":"67","author":"RK Venkata","year":"2007","unstructured":"Venkata RK et al. (2007) Tuberculosis in chronic kidney disease. Clin Nephrol 67: 217\u2013220","journal-title":"Clin Nephrol"},{"key":"BFncpneph0762_CR36","first-page":"176","volume":"32","author":"S Zyga","year":"2006","unstructured":"Zyga S and Tourouki G (2006) Tuberculosis in haemodialysis: a problem making a comeback. EDTNA ERCA J 32: 176\u2013178","journal-title":"EDTNA ERCA J"},{"key":"BFncpneph0762_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2215\/CJN.01280406","volume":"2","author":"L Passalent","year":"2007","unstructured":"Passalent L et al. (2007) Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol 2: 68\u201373","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFncpneph0762_CR38","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1093\/ndt\/14.12.2857","volume":"14","author":"A Korzets","year":"1999","unstructured":"Korzets A and Gafter U (1999) Tuberculosis prophylaxis for the chronically dialysed patient\u2014yes or no. Nephrol Dial Transplant 14: 2857\u20132859","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0762_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1081\/JDI-65379","volume":"27","author":"E Dogan","year":"2005","unstructured":"Dogan E et al. (2005) Tuberculin skin test results and the booster phenomenon in two-step tuberculin skin testing in hemodialysis patients? Ren Fail 27: 425\u2013428","journal-title":"Ren Fail"},{"key":"BFncpneph0762_CR40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/ndt\/gfg569","volume":"19","author":"A Wauters","year":"2004","unstructured":"Wauters A et al. (2004) The value of tuberculin skin testing in haemodialysis patients. Nephrol Dial Transplant 19: 433\u2013438","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0762_CR41","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1111\/j.1600-6143.2004.00545.x","volume":"4","author":"MM Klote","year":"2004","unstructured":"Klote MM et al. (2004) Mycobacterium tuberculosis infection incidence in hospitalized renal transplant patients in the United States, 1998\u20132000. Am J Transplant 4: 1523\u20131528","journal-title":"Am J Transplant"},{"key":"BFncpneph0762_CR42","unstructured":"[No authors listed] (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161: S221\u2013S247"},{"key":"BFncpneph0762_CR43","doi-asserted-by":"crossref","unstructured":"American Thoracic Society; Centers for Disease Control and Prevention; Infectious Diseases Society of America (2005) American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med 172: 1169\u20131227","DOI":"10.1164\/rccm.2508001"},{"key":"BFncpneph0762_CR44","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1053\/j.ajkd.2003.08.019","volume":"42","author":"G DaRoza","year":"2003","unstructured":"DaRoza G et al. (2003) Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis 42: 1184\u20131192","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0762_CR45","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1046\/j.1523-1755.2003.00787.x","volume":"63","author":"DT Gilbertson","year":"2003","unstructured":"Gilbertson DT et al. (2003) Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int 63: 738\u2013743","journal-title":"Kidney Int"},{"key":"BFncpneph0762_CR46","unstructured":"[No authors listed] (1997) Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 46: 1\u201324"},{"key":"BFncpneph0762_CR47","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/ndt\/11.3.468","volume":"11","author":"A Fuchshuber","year":"1996","unstructured":"Fuchshuber A et al. (1996) Pneumococcal vaccine in children and young adults with chronic renal disease. Nephrol Dial Transplant 11: 468\u2013473","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0762_CR48","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2165\/00003088-199222060-00003","volume":"22","author":"DW Johnson","year":"1992","unstructured":"Johnson DW and Fleming SJ (1992) The use of vaccines in renal failure. Clin Pharmacokinet 22: 434\u2013446","journal-title":"Clin Pharmacokinet"},{"key":"BFncpneph0762_CR49","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1001\/archinte.1986.00360200116019","volume":"146","author":"CC Linnemann Jr","year":"1986","unstructured":"Linnemann CC Jr et al. (1986) Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. Arch Intern Med 146: 1554\u20131556","journal-title":"Arch Intern Med"},{"issue":"Suppl 2","key":"BFncpneph0762_CR50","first-page":"S3","volume":"1","author":"BL Kasiske","year":"2001","unstructured":"Kasiske BL et al. (2001) The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant 1 (Suppl 2): S3\u2013S95","journal-title":"Am J Transplant"},{"key":"BFncpneph0762_CR51","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1038\/sj.ki.5001908","volume":"70","author":"SK Olsen","year":"2006","unstructured":"Olsen SK and Brown RS Jr (2006) Hepatitis B treatment: lessons for the nephrologist. Kidney Int 70: 1897\u20131904","journal-title":"Kidney Int"},{"key":"BFncpneph0762_CR52","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1046\/j.1525-139X.2002.00051.x","volume":"15","author":"JI Tokars","year":"2002","unstructured":"Tokars JI et al. (2002) National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial 15: 162\u2013171","journal-title":"Semin Dial"},{"key":"BFncpneph0762_CR53","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/hep.510310232","volume":"31","author":"H Marusawa","year":"2000","unstructured":"Marusawa H et al. (2000) Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 31: 488\u2013495","journal-title":"Hepatology"},{"key":"BFncpneph0762_CR54","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/jhep.2001.25172","volume":"34","author":"C Brechot","year":"2001","unstructured":"Brechot C et al. (2001) Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely \u201coccult\u201d. Hepatology 34: 194\u2013203","journal-title":"Hepatology"},{"key":"BFncpneph0762_CR55","first-page":"327","volume":"19","author":"D Siagris","year":"2006","unstructured":"Siagris D et al. (2006) Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection. J Nephrol 19: 327\u2013333","journal-title":"J Nephrol"},{"key":"BFncpneph0762_CR56","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1492-7535.2005.01155.x","volume":"9","author":"E Lacson","year":"2005","unstructured":"Lacson E et al. (2005) Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease. Hemodial Int 9: 367\u2013375","journal-title":"Hemodial Int"},{"key":"BFncpneph0762_CR57","doi-asserted-by":"publisher","first-page":"c89","DOI":"10.1159\/000092016","volume":"103","author":"K Chow","year":"2006","unstructured":"Chow K et al. (2006) Antibody response to hepatitis B vaccine in end-stage renal disease patients. Nephron Clin Pract 103: c89\u2013c93","journal-title":"Nephron Clin Pract"},{"key":"BFncpneph0762_CR58","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1053\/j.ajkd.2003.12.052","volume":"43","author":"KF Chau","year":"2004","unstructured":"Chau KF et al. (2004) Efficacy and side effects of intradermal hepatitis B vaccination in CAPD patients: a comparison with the intramuscular vaccination. Am J Kidney Dis 43: 910\u2013917","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0762_CR59","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1053\/ajkd.2000.19099","volume":"36","author":"AF Charest","year":"2000","unstructured":"Charest AF et al. (2000) A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 36: 976\u2013982","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0762_CR60","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1365-2036.2006.03002.x","volume":"24","author":"F Fabrizi","year":"2006","unstructured":"Fabrizi F et al. (2006) Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease. Aliment Pharmacol Ther 24: 497\u2013506","journal-title":"Aliment Pharmacol Ther"},{"key":"BFncpneph0762_CR61","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1111\/j.1523-1755.2005.00689.x","volume":"68","author":"NK Tong","year":"2005","unstructured":"Tong NK et al. (2005) Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int 68: 2298\u20132303","journal-title":"Kidney Int"},{"key":"BFncpneph0762_CR62","first-page":"183","volume":"47","author":"SK Agarwal","year":"1999","unstructured":"Agarwal SK et al. (1999) Comparison of two schedules of hepatitis B vaccination in patients with mild, moderate and severe renal failure. J Assoc Physicians India 47: 183\u2013185","journal-title":"J Assoc Physicians India"},{"key":"BFncpneph0762_CR63","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/ndt\/17.10.1825","volume":"17","author":"EH Fleischmann","year":"2002","unstructured":"Fleischmann EH et al. (2002) Active immunization against hepatitis A in dialysis patients. Nephrol Dial Transplant 17: 1825\u20131828","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0762_CR64","first-page":"427","volume":"97","author":"RJ Jacobs","year":"2002","unstructured":"Jacobs RJ et al. (2002) The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A. Am J Gastroenterol 97: 427\u2013434","journal-title":"Am J Gastroenterol"},{"key":"BFncpneph0762_CR65","first-page":"176","volume":"2","author":"EC Oldfield 3rd","year":"2002","unstructured":"Oldfield EC 3rd (2002) Evaluation of chronic diarrhea in patients with human immunodeficiency virus infection. Rev Gastroenterol Disord 2: 176\u2013188","journal-title":"Rev Gastroenterol Disord"},{"key":"BFncpneph0762_CR66","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1001\/archinte.167.12.1271","volume":"167","author":"JI Tsui","year":"2007","unstructured":"Tsui JI et al. (2007) Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med 167: 1271\u20131276","journal-title":"Arch Intern Med"},{"key":"BFncpneph0762_CR67","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1053\/j.ajkd.2004.12.014","volume":"45","author":"S Bergman","year":"2005","unstructured":"Bergman S et al. (2005) Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis 45: 684\u2013689","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0762_CR68","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1111\/j.1523-1755.2004.00649.x","volume":"65","author":"RB Fissell","year":"2004","unstructured":"Fissell RB et al. (2004) Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 65: 2335\u20132342","journal-title":"Kidney Int"},{"key":"BFncpneph0762_CR69","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2893.2007.00868.x","volume":"14","author":"F Fabrizi","year":"2007","unstructured":"Fabrizi F et al. (2007) The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat 14: 697\u2013703","journal-title":"J Viral Hepat"},{"key":"BFncpneph0762_CR70","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","volume":"354","author":"P Maisonneuve","year":"1999","unstructured":"Maisonneuve P et al. (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354: 93\u201399","journal-title":"Lancet"},{"key":"BFncpneph0762_CR71","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.3748\/wjg.v11.i14.2067","volume":"11","author":"CN Yeh","year":"2005","unstructured":"Yeh CN et al. (2005) Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol 11: 2067\u20132071","journal-title":"World J Gastroenterol"},{"key":"BFncpneph0762_CR72","first-page":"16","volume":"28","author":"DN Amarapurkar","year":"2007","unstructured":"Amarapurkar DN et al. (2007) Monotherapy with peginterferon alpha-2b {12 kDa} for chronic hepatitis C infection in patients undergoing haemodialysis. Trop Gastroenterol 28: 16\u201318","journal-title":"Trop Gastroenterol"},{"key":"BFncpneph0762_CR73","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/01.meg.0000252626.73172.f3","volume":"19","author":"CM Rocha","year":"2007","unstructured":"Rocha CM et al. (2007) Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance. Eur J Gastroenterol Hepatol 19: 119\u2013123","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BFncpneph0762_CR74","first-page":"794","volume":"19","author":"A Covic","year":"2006","unstructured":"Covic A et al. (2006) Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: results from a large, multicenter audit. J Nephrol 19: 794\u2013801","journal-title":"J Nephrol"},{"key":"BFncpneph0762_CR75","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.transproceed.2004.07.025","volume":"36","author":"DH Mousa","year":"2004","unstructured":"Mousa DH et al. (2004) Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C. Transplant Proc 36: 1831\u20131834","journal-title":"Transplant Proc"},{"key":"BFncpneph0762_CR76","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jhep.2006.12.016","volume":"46","author":"M Rendina","year":"2007","unstructured":"Rendina M et al. (2007) The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant. J Hepatol 46: 768\u2013774","journal-title":"J Hepatol"},{"key":"BFncpneph0762_CR77","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/jhep.2002.34613","volume":"36","author":"F Fabrizi","year":"2002","unstructured":"Fabrizi F et al. (2002) Hepatitis C infection and the patient with end-stage renal disease. Hepatology 36: 3\u201310","journal-title":"Hepatology"},{"key":"BFncpneph0762_CR78","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1365-2893.2005.00680.x","volume":"13","author":"A Bruchfeld","year":"2006","unstructured":"Bruchfeld A et al. (2006) Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients. J Viral Hepat 13: 316\u2013321","journal-title":"J Viral Hepat"},{"key":"BFncpneph0762_CR79","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2215\/CJN.00470107","volume":"2","author":"LS Dalrymple","year":"2007","unstructured":"Dalrymple LS et al. (2007) Hepatitis C virus infection and the prevalence of renal insufficiency. Clin J Am Soc Nephrol 2: 715\u2013721","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFncpneph0762_CR80","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/snep.2002.33677","volume":"22","author":"JM Morales","year":"2002","unstructured":"Morales JM et al. (2002) Hepatitis C virus infection and kidney transplantation. Semin Nephrol 22: 365\u2013374","journal-title":"Semin Nephrol"},{"key":"BFncpneph0762_CR81","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1097\/01.tp.0000238898.14393.c9","volume":"82","author":"N Kamar","year":"2006","unstructured":"Kamar N et al. (2006) Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant. Transplantation 82: 853\u2013856","journal-title":"Transplantation"},{"key":"BFncpneph0762_CR82","doi-asserted-by":"crossref","unstructured":"Baid-Agrawal S et al. (2007) Hepatitis C virus infection in haemodialysis and kidney transplant patients. Rev Med Virol [10.1002\/rmv.565]","DOI":"10.1002\/rmv.565"},{"key":"BFncpneph0762_CR83","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1001\/archinte.166.17.1884","volume":"166","author":"NI Parikh","year":"2006","unstructured":"Parikh NI et al. (2006) Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med 166: 1884\u20131891","journal-title":"Arch Intern Med"},{"key":"BFncpneph0762_CR84","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ncpneph0129","volume":"2","author":"V Krane","year":"2006","unstructured":"Krane V and Wanner C (2006) At which stage of chronic kidney disease should dyslipidemia be treated. Nat Clin Pract Nephrol 2: 176\u2013177","journal-title":"Nat Clin Pract Nephrol"},{"issue":"Suppl 99","key":"BFncpneph0762_CR85","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1111\/j.1523-1755.2005.09916.x","volume":"68","author":"A Cases","year":"2005","unstructured":"Cases A and Coll E (2005) Dyslipidemia and the progression of renal disease in chronic renal failure patients. Kidney Int 68 (Suppl 99): S87\u2013S93","journal-title":"Kidney Int"},{"key":"BFncpneph0762_CR86","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/ki.1997.260","volume":"51","author":"LG Hunsicker","year":"1997","unstructured":"Hunsicker LG et al. (1997) Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51: 1908\u20131919","journal-title":"Kidney Int"},{"key":"BFncpneph0762_CR87","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/ndt\/12.9.1908","volume":"12","author":"O Samuelsson","year":"1997","unstructured":"Samuelsson O et al. (1997) Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 12: 1908\u20131915","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0762_CR88","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1056\/NEJMoa043545","volume":"353","author":"C Wanner","year":"2005","unstructured":"Wanner C et al. (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353: 238\u2013248","journal-title":"N Engl J Med"},{"key":"BFncpneph0762_CR89","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1046\/j.1523-1755.2002.00109.x","volume":"61","author":"SL Seliger","year":"2002","unstructured":"Seliger SL et al. (2002) HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int 61: 297\u2013304","journal-title":"Kidney Int"},{"key":"BFncpneph0762_CR90","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1053\/j.ajkd.2004.09.025","volume":"45","author":"NA Mason","year":"2005","unstructured":"Mason NA et al. (2005) HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients. Am J Kidney Dis 45: 119\u2013126","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0762_CR91","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S1262-3636(07)70292-6","volume":"32","author":"T Meas","year":"2006","unstructured":"Meas T et al. (2006) Elevation of CKP induced by ezetimibe in monotherapy: report on two cases. Diabetes Metab 32: 364\u2013366","journal-title":"Diabetes Metab"},{"key":"BFncpneph0762_CR92","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1097\/01.TP.0000085287.03333.FC","volume":"76","author":"NR Barshes","year":"2003","unstructured":"Barshes NR et al. (2003) Sirolimus\u2013atorvastatin drug interaction in the pancreatic islet transplant recipient. Transplantation 76: 1649\u20131650","journal-title":"Transplantation"},{"key":"BFncpneph0762_CR93","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.2337\/dc05-1887","volume":"29","author":"T Oomichi","year":"2006","unstructured":"Oomichi T et al. (2006) Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study. Diabetes Care 29: 1496\u20131500","journal-title":"Diabetes Care"},{"key":"BFncpneph0762_CR94","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.0894-0959.2004.17346.x","volume":"17","author":"RW Snyder","year":"2004","unstructured":"Snyder RW and Berns JS (2004) Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Semin Dial 17: 365\u2013370","journal-title":"Semin Dial"},{"key":"BFncpneph0762_CR95","unstructured":"[No authors listed] (2007) KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 49 (Suppl 2): S12\u2013S154"},{"key":"BFncpneph0762_CR96","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0272-6386(89)80187-8","volume":"14","author":"FK Port","year":"1989","unstructured":"Port FK et al. (1989) Neoplasms in dialysis patients: a population-based study. Am J Kidney Dis 14: 119\u2013123","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0762_CR97","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1023\/A:1014489911153","volume":"33","author":"K Cengiz","year":"2002","unstructured":"Cengiz K (2002) Increased incidence of neoplasia in chronic renal failure (20-year experience). Int Urol Nephrol 33: 121\u2013126","journal-title":"Int Urol Nephrol"},{"key":"BFncpneph0762_CR98","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000013314","volume":"18","author":"S Vamvakas","year":"1998","unstructured":"Vamvakas S et al. (1998) Cancer in end-stage renal disease: potential factors involved. Am J Nephrol 18: 89\u201395","journal-title":"Am J Nephrol"},{"key":"BFncpneph0762_CR99","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/01.ASN.0000039608.81046.81","volume":"14","author":"JH Stewart","year":"2003","unstructured":"Stewart JH et al. (2003) Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14: 197\u2013207","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0762_CR100","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2215\/CJN.03931106","volume":"2","author":"JL Holley","year":"2007","unstructured":"Holley JL (2007) Screening, diagnosis, and treatment of cancer in long-term dialysis patients. Clin J Am Soc Nephrol 2: 604\u2013610","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 2","key":"BFncpneph0762_CR101","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1097\/01.ASN.0000070145.00225.EC","volume":"14","author":"WF Owen Jr","year":"2003","unstructured":"Owen WF Jr (2003) Patterns of care for patients with chronic kidney disease in the United States: dying for improvement. J Am Soc Nephrol 14 (Suppl 2): S76\u2013S80","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0762_CR102","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1046\/j.1523-1755.2002.00374.x","volume":"61","author":"MD Denton","year":"2002","unstructured":"Denton MD et al. (2002) Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int 61: 2201\u20132209","journal-title":"Kidney Int"},{"key":"BFncpneph0762_CR103","first-page":"5","volume":"14","author":"R Peces","year":"2003","unstructured":"Peces R (2003) Malignancy and chronic renal failure. Saudi J Kidney Dis Transpl 14: 5\u201314","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"BFncpneph0762_CR104","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0272-6386(87)80009-4","volume":"10","author":"JW Smith","year":"1987","unstructured":"Smith JW et al. (1987) Acquired renal cystic disease: two cases of associated adenocarcinoma and a renal ultrasound survey of a peritoneal dialysis population. Am J Kidney Dis 10: 41\u201346","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0762_CR105","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/1097-0142(19860501)57:9<1871::AID-CNCR2820570929>3.0.CO;2-3","volume":"57","author":"PN Bretan Jr","year":"1986","unstructured":"Bretan PN Jr et al. (1986) Chronic renal failure: a significant risk factor in the development of acquired renal cysts and renal cell carcinoma. Case reports and review of the literature. Cancer 57: 1871\u20131879","journal-title":"Cancer"},{"key":"BFncpneph0762_CR106","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/ki.1995.286","volume":"48","author":"FP Sarasin","year":"1995","unstructured":"Sarasin FP et al. (1995) Screening for acquired cystic kidney disease: a decision analytic perspective. Kidney Int 48: 207\u2013219","journal-title":"Kidney Int"},{"key":"BFncpneph0762_CR107","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1093\/ndt\/gfh458","volume":"19","author":"R Peces","year":"2004","unstructured":"Peces R et al. (2004) Renal cell carcinoma co-existent with other renal disease: clinico-pathological features in pre-dialysis patients and those receiving dialysis or renal transplantation. Nephrol Dial Transplant 19: 2789\u20132796","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0762_CR108","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/canjclin.56.1.11","volume":"56","author":"RA Smith","year":"2006","unstructured":"Smith RA et al. (2006) American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 56: 11\u201325","journal-title":"CA Cancer J Clin"},{"key":"BFncpneph0762_CR109","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1001\/jama.296.19.2336","volume":"296","author":"LC Walter","year":"2006","unstructured":"Walter LC et al. (2006) PSA screening among elderly men with limited life expectancies. JAMA 296: 2336\u20132342","journal-title":"JAMA"},{"key":"BFncpneph0762_CR110","unstructured":"[No authors listed] (2000) Prostate-specific antigen (PSA) best practice policy: American Urological Association (AUA). Oncology (Williston Park) 14: 267\u2013272"},{"key":"BFncpneph0762_CR111","unstructured":"National Comprehensive Cancer Network (2007) NCCN Clinical Practice Guidelines in Oncology. [ http:\/\/www.nccn.org ]"},{"key":"BFncpneph0762_CR112","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.juro.2007.07.010","volume":"178","author":"VN Giri","year":"2007","unstructured":"Giri VN et al. (2007) Prostate cancer risk assessment program: a 10-year update of cancer detection. J Urol 178: 1920\u20131924","journal-title":"J Urol"},{"key":"BFncpneph0762_CR113","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0090-4295(99)00010-2","volume":"53","author":"B Djavan","year":"1999","unstructured":"Djavan B et al. (1999) Impact of chronic dialysis on serum PSA, free PSA, and free\/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis. Urology 53: 1169\u20131174","journal-title":"Urology"},{"key":"BFncpneph0762_CR114","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1464-410X.1995.tb07272.x","volume":"75","author":"JJ Morton","year":"1995","unstructured":"Morton JJ et al. (1995) Influence of end-stage renal disease and renal transplantation on serum prostate-specific antigen. Br J Urol 75: 498\u2013501","journal-title":"Br J Urol"},{"key":"BFncpneph0762_CR115","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1464-410X.2006.06374.x","volume":"98","author":"Y Wada","year":"2006","unstructured":"Wada Y et al. (2006) Mass screening for prostate cancer in patients with end-stage renal disease: a comparative study. BJU Int 98: 794\u2013797","journal-title":"BJU Int"},{"key":"BFncpneph0762_CR116","first-page":"93","volume":"75","author":"A Gheissari","year":"1990","unstructured":"Gheissari A et al. (1990) Gastrointestinal hemorrhage in end stage renal disease patients. Int Surg 75: 93\u201395","journal-title":"Int Surg"},{"key":"BFncpneph0762_CR117","first-page":"198","volume":"42","author":"M Akmal","year":"1994","unstructured":"Akmal M et al. (1994) The prevalence and significance of occult blood loss in patients with predialysis advanced chronic renal failure (CRF), or receiving dialytic therapy. Clin Nephrol 42: 198\u2013202","journal-title":"Clin Nephrol"},{"key":"BFncpneph0762_CR118","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1053\/j.ajkd.2006.07.002","volume":"48","author":"EJ Bini","year":"2006","unstructured":"Bini EJ et al. (2006) Predictive value of a positive fecal occult blood test increases as the severity of CKD worsens. Am J Kidney Dis 48: 580\u2013586","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0762_CR119","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/archinte.1996.00440110117016","volume":"156","author":"GM Chertow","year":"1996","unstructured":"Chertow GM et al. (1996) Cost-effectiveness of cancer screening in end-stage renal disease. Arch Intern Med 156: 1345\u20131350","journal-title":"Arch Intern Med"},{"key":"BFncpneph0762_CR120","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1053\/j.ajkd.2006.05.001","volume":"48","author":"M Castellanos","year":"2006","unstructured":"Castellanos M et al. (2006) Increased breast calcifications in women with ESRD on dialysis: implications for breast cancer screening. Am J Kidney Dis 48: 301\u2013306","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0762_CR121","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/ndt\/17.10.1786","volume":"17","author":"S Kajbaf","year":"2002","unstructured":"Kajbaf S et al. (2002) Cancer screening and life expectancy of Canadian patients with kidney failure. Nephrol Dial Transplant 17: 1786\u20131789","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0762_CR122","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1001\/archinte.166.11.1203","volume":"166","author":"LC Walter","year":"2006","unstructured":"Walter LC et al. (2006) Targeting screening mammography according to life expectancy among women undergoing dialysis. Arch Intern Med 166: 1203\u20131208","journal-title":"Arch Intern Med"},{"key":"BFncpneph0762_CR123","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0272-6386(00)70332-5","volume":"35","author":"CJ LeBrun","year":"2000","unstructured":"LeBrun CJ et al. (2000) Life expectancy benefits of cancer screening in the end-stage renal disease population. Am J Kidney Dis 35: 237\u2013243","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0762_CR124","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1053\/jarr.2000.8119","volume":"7","author":"LH Beck","year":"2000","unstructured":"Beck LH (2000) Screening and preventive health practices for the end-stage renal disease patient. Adv Ren Replace Ther 7: 195\u2013201","journal-title":"Adv Ren Replace Ther"}],"container-title":["Nature Clinical Practice Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0762","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0762.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0762.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T12:32:55Z","timestamp":1708605175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,19]]},"references-count":124,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["BFncpneph0762"],"URL":"https:\/\/doi.org\/10.1038\/ncpneph0762","relation":{},"ISSN":["1745-8323","1745-8331"],"issn-type":[{"value":"1745-8323","type":"print"},{"value":"1745-8331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,19]]}}}